<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04926571</url>
  </required_header>
  <id_info>
    <org_study_id>RQ004-1-20210610</org_study_id>
    <nct_id>NCT04926571</nct_id>
  </id_info>
  <brief_title>Dexamethasone and COVID-19 Inpatient Mortality</brief_title>
  <official_title>Effect of Dexamethasone on Inpatient Mortality Among Hospitalized COVID-19 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aetion, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aetion, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to assess the effectiveness of dexamethasone initiation to reduce the risk of&#xD;
      inpatient mortality within 28 days among US patients hospitalized with COVID-19 diagnosis or&#xD;
      SARS-CoV-2 infection, overall and stratified by COVID-19 severity subgroups.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a non-randomized, non-interventional study that is part of a research collaboration&#xD;
      agreement between the US Food and Drug Administration (FDA) and Aetion to use real-world data&#xD;
      to advance the understanding and the natural history of COVID-19 in specific patient&#xD;
      populations, as well as treatment and diagnostic patterns during the coronavirus disease&#xD;
      (COVID-19) pandemic.&#xD;
&#xD;
      This study compares inpatient mortality within 28 days among US patients hospitalized with&#xD;
      COVID-19 diagnosis or SARS-CoV-2 infection who initiate dexamethasone treatment with a&#xD;
      matched cohort of patients with 'standard of care' who are non-users of corticosteroids of&#xD;
      interest (dexamethasone, prednisone, methylprednisolone, hydrocortisone). Patients are&#xD;
      compared overall and and stratified by COVID-19 severity subgroups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>28 days</time_frame>
    <description>Mortality within 28 days of admission</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">20000</enrollment>
  <condition>Coronavirus</condition>
  <arm_group>
    <arm_group_label>Dexamethasone versus non-users of corticosteroids</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone versus non-users of dexamethasone</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone versus methylprednisolone active comparator</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone Oral</intervention_name>
    <description>New users of Dexamethasone</description>
    <arm_group_label>Dexamethasone versus methylprednisolone active comparator</arm_group_label>
    <arm_group_label>Dexamethasone versus non-users of corticosteroids</arm_group_label>
    <arm_group_label>Dexamethasone versus non-users of dexamethasone</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitalized Patients with confirmed COVID-19 (diagnosis of U07.1 or positive or&#xD;
        presumptive positive SARS-CoV-2 diagnostic laboratory test result) occurring between 21&#xD;
        days prior to the hospital admission date and the treatment index date.&#xD;
&#xD;
        Patients will enter the cohort upon the admission date of the first qualifying inpatient&#xD;
        hospitalization observed in the hospital chargemaster data. The first eligible cohort entry&#xD;
        date is 01-April-2020, the date when the ICD-10 code for COVID-19 diagnosis was added.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Hospitalized Patients with confirmed COVID-19 (diagnosis of U07.1 or positive or&#xD;
             presumptive positive SARS-CoV-2 diagnostic laboratory test result) occurring between&#xD;
             21 days prior to the hospital admission date and the treatment index date.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No interaction with the healthcare system (medical encounter) in the 183 days prior to&#xD;
             and including hospital admission (Day -183 to Day 0) to minimize the potential for&#xD;
             misclassification of baseline covariates and/or new use&#xD;
&#xD;
          -  No age or sex recorded in the 183 days prior to and including hospital admission (Day&#xD;
             -183 to Day 0) as required for matching&#xD;
&#xD;
          -  No geographic region recorded in 183 days prior to and including hospital admission&#xD;
             (Day -183 to Day 0) as necessary to adjust for regional variation&#xD;
&#xD;
          -  Any recorded use of any CSI (dispensing or remaining supply) in the 90-day washout&#xD;
             prior to the treatment index date (Day T-90 to Day T-1) to satisfy new use definition&#xD;
&#xD;
          -  Any record of a COVID-19 vaccine recorded on or any time prior to the treatment index&#xD;
             date given that these patients are assumed to be selectively different (Day S to Day&#xD;
             T)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Aetion, Inc.</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 11, 2021</study_first_submitted>
  <study_first_submitted_qc>June 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2021</study_first_posted>
  <last_update_submitted>June 14, 2021</last_update_submitted>
  <last_update_submitted_qc>June 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aetion, Inc.</investigator_affiliation>
    <investigator_full_name>Nicolle Gatto</investigator_full_name>
    <investigator_title>Senior Vice President</investigator_title>
  </responsible_party>
  <keyword>treatment</keyword>
  <keyword>dexamethasone</keyword>
  <keyword>corticosteroid</keyword>
  <keyword>mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Study results will report aggregated findings</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 10, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/71/NCT04926571/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

